American medicine. A bitter pricing pill. A lot to cut drug prices is changing how pharma firms make medicines. It is already changing how pharm...
Backers say changes needed to spur innovation, but critics disagree
A flurry of deals suggests that drug firms favour buying their way out of trouble. Will face competition from cheaper copycats once key patents exp...
Politicians are attacking IP protection, but shareholders are Big Pharma’s bigger headache | Business
Create
Sign in to save articles, videos, notes, and other finds.